�AmniScreen� is the number one and simply FDA-approved at home screening test for amnic fluid escape during maternity, a status that may lead to serious complications such as infection and preterm labor. AmniScreen� is now available by prescription medicine only and can be purchased in retail pharmacies. AmniScreen� is a scanty liner quiz that offers the convenience of at home screening for pregnant women who know unexplained vaginal wetness. One AmniScreen� test kit contains three step-in liners and three drying
trays, offering screening precisely about anytime, anywhere.
"AmniScreen� may offer reassurance to women concerned about unexplained vaginal wetness during pregnancy," says Nancy Jasper, MD, Assistant Clinical Professor, Department of OB/GYN, Columbia University, College of Physicians and Surgeons. "It's important to know when wetness crataegus oxycantha be caused by amniotic fluid leak. This new tool provides pregnant women with an effective way to identify unexplained wetness, with easy-to-read results that should be discussed with their healthcare provider. This important new test is an additional resource which may provide healthcare providers with information to assist determine the necessity of a patient hospital or office travel to."
How AmniScreen� Works
AmniScreen� industrial plant by detecting elevated pH levels, which may suggest amniotic unstable leakage. Patients are instructed to account or express test results to their healthcare provider for reading and medical care. The pivotal visitation demonstrated that AmniScreen� detected amniotic fluid leakage about 96% of the time. During the trial, patient-read results and clinician-read results matched more than than 97% of the time.
Potential Candidates
Pregnant women who experience unexplained vaginal wetness ar potential candidates for AmniScreen�. Additional candidates include bad pregnant women, women wHO have undergone amniocentesis, suffer experienced prior amniotic liquid leakage, and those world Health Organization are concerned about unexplained wetness.
Safety Information
The AmniScreen� Home Detection Liner Kit is intended to discover possible leak of amniotic fluid when vaginal wetness is experient during maternity by indicating pH horizontal surface. A pH level greater than or equal to 5.2 produces a blue-green color. Patients ar instructed to report or show essay results to their health care provider for interpretation and medical fear.
AmniScreen� should not be used if less than 12 hours have passed since sexual intercourse or vaginal douching. AmniScreen� should not be used if there is vaginal haemorrhage or maculation. A healthcare provider should be consulted if there is unexplained wetness, vaginal bleeding or spotting, or suspicion of vaginal infection.
Please see full Prescribing Information. For more info,
please call http://www.amniscreen.com
About Barr Pharmaceuticals, Inc.
Barr Pharmaceuticals, Inc. is a world specialty pharmaceutic company that operates in more than 30 countries worldwide and is engaged in the development, cook up and marketing of generic and proprietorship pharmaceuticals, biopharmaceuticals and fighting pharmaceutical ingredients. A holding company, Barr operates through its dealer subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary products in the U.S. and approximately 1,025 products globally outside of the U.S. For more information, visit hypertext transfer protocol://www.barrlabs.com.
About Duramed Pharmaceuticals, Inc.
Duramed Pharmaceuticals, Inc., which develops and markets proprietary (branded) pharmaceutical products in North America, focuses primarily on products for women and emphasizes the development and marketing of products for reproductive and menopausal inevitably. Currently, Duramed markets 27 proprietary pharmaceutical products.
Barr Pharmaceuticals, Inc.
More info
